NCT05800704View on ClinicalTrials.gov

Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®

NAActive, not recruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
C. Difficile Enteritis
Interventions
DIETARY_SUPPLEMENT

Nagasin

Lactobacillus, Lactococcus and Bifidobacteria strains with antimicrobial effect against C. difficile

DIETARY_SUPPLEMENT

maltodextrin

maltodextrin (placebo comparator)

Trial Locations (6)

3010

Inselspital Bern, Bern

4410

Kantonsspital Baselland, Liestal

6000

Luzerner Kantonsspital, Lucerne

8063

Stadtspital Zürich, Zurich

8091

University Hospital Zurich, Zurich

8400

Kantonsspital Winterthur, Winterthur

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Stadtspital Zürich

OTHER

collaborator

Kantonsspital Winterthur KSW

OTHER

collaborator

Luzerner Kantonsspital

OTHER

collaborator

Cantonal Hosptal, Baselland

OTHER

lead

University of Zurich

OTHER